Robinswood Financial LLC

Position in NVS — Novartis AG

CIK 2139748 KIRKLAND, WA

Position in NVS

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$10,343

+$262 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,536

of 1,603 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Robinswood Financial LLC holds $915,768 across 12 Drug Manufacturers - General names. NVS ranks #10 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,035	$516,828
2	MRK	Merck & Co., Inc.	1,059	$136,081
3	LLY	ELI LILLY & Co	81	$97,153
4	PFE	Pfizer Inc	1,524	$36,697
5	AMGN	Amgen Inc	100	$36,212
6	ABBV	AbbVie Inc.	83	$20,886
7	AZN	Astrazeneca PLC	109	$20,668
8	SNY	Sanofi	432	$18,429

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,343	66	0.0%	Shares	Sole	2026-07-15
2026-03-31	$10,081	66	0.0%	Shares	Sole	2026-07-13
2025-12-31	$9,099	66	0.0%	Shares	Sole	2026-07-14
2025-09-30	$8,463	66	0.0%	Shares	Sole	2026-07-14
2025-06-30	$7,986	66	0.0%	Shares	Sole	2026-07-14
2025-03-31	$7,357	66	0.0%	Shares	Sole	2026-07-14
2024-12-31	$6,422	66	0.0%	Shares	Sole	2026-07-15
2024-09-30	$7,591	66	—	Shares	Sole	2026-07-15
No filing history on record for this holder in this stock.